MYCELIUM EDI LIMITED

Company number 13952057 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

MYCELIUM EDI LIMITED - Analysis Report

Company Number: 13952057

Analysis Date: 2025-07-20 15:08 UTC

Financial Health Assessment: MYCELIUM EDI LIMITED


1. Financial Health Score: Grade D

Explanation:
MYCELIUM EDI LIMITED is classified as a dormant company with minimal financial activity. The company’s net assets and shareholders’ funds remain at a nominal £2 over the last three years, indicating no operational business transactions or growth. While there are no liabilities or losses reported, the absence of active trading or income generation places the company in a fragile financial state—more akin to a patient in remission rather than robust health.


2. Key Vital Signs

Metric Value (£) Interpretation
Net Assets 2 Essentially nominal; no asset base to support operations
Shareholders’ Funds 2 Reflects initial capital only; no retained earnings
Operational Status Dormant No trading activity; no revenue, expenses, or cash flow
Filing Status Up to date No overdue filings; compliance is healthy
Company Age ~2 years Very young; likely pre-operational or in incubation
Control Structure Two shareholders with 25-50% control each Stable governance, but small ownership base

Interpretation:
The vital signs indicate a company in a state of financial dormancy. There are no symptoms of distress such as debt or losses, but equally, there is no sign of healthy cash flow or asset growth that would suggest active business development.


3. Diagnosis

MYCELIUM EDI LIMITED is currently a dormant private limited company, having filed dormant accounts consistently for the last three financial years. The company’s balance sheet shows only the issued share capital of £2, with no other assets or liabilities. No trading activity or financial transactions have occurred, indicating the business is either in a start-up incubation phase, on hold, or possibly a holding vehicle for intellectual property or future projects.

From a financial wellness perspective, the company shows no signs of operational distress but also no indicators of financial vitality or growth. This is a neutral condition, akin to a patient who is stable but inactive, without pathology but without health improvement either.


4. Recommendations

  • Activate Trading Operations: To move from dormancy to financial health, the company should initiate trading activities, generating revenue and building working capital. Dormancy means no income or operating cash flow, which is unsustainable long term if the company intends to be a going concern.

  • Develop a Financial Plan: Prepare a clear business plan outlining projected income, expenses, and capital requirements. Early-stage financial planning can help identify needed investment, timing of cash inflows, and break-even points.

  • Monitor Compliance: Continue timely filing of dormant accounts and confirmation statements to avoid penalties and maintain good standing with Companies House.

  • Consider Capital Injection: If the company intends to grow, it may require additional capital beyond the nominal £2 issued share capital. Engaging shareholders for further funding or external investors could improve financial resilience.

  • Review Governance: The company currently has two controlling shareholders with equal voting rights and director appointment powers. Maintaining clear governance and decision-making protocols will be important as the company transitions to active trading.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.